We are live on ! Find out more
PCM

Prelude Capital Management Portfolio holdings

AUM $1.31B
1-Year Est. Return 62.02%
This Fund
S&P 500
This Quarter Est. Return
-0.89%
1 Year Est. Return
+62.02%
3 Year Est. Return
+164.16%
5 Year Est. Return
+274.13%
10 Year Est. Return
+2,470.2%
AUM
$2.22B
AUM Growth
+$186M
Cap. Flow
+$231M
Cap. Flow %
10.43%
Top 10 Hldgs %
42.94%
Holding
2,313
New
704
Increased
422
Reduced
406
Closed
646

Sector Composition

Rank Sector Weight
1 Technology 6.33%
2 Healthcare 5.48%
3 Consumer Discretionary 4.35%
4 Industrials 3%
5 Real Estate 2.31%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GFN
1526
DELISTED
General Finance Corporation
GFN
$7K ﹤0.01%
+823
New +$6.58K
AFG icon
1527
American Financial Group
AFG
$12.1B
$6K ﹤0.01%
55
-1,656
-97% -$171K
AR icon
1528
PUT
Antero Resources
AR
$10.7B
$6K ﹤0.01%
+2,000
New +$8.15K
BMRN icon
1529
BioMarin Pharmaceuticals
BMRN
$12.4B
$6K ﹤0.01%
83
-11,550
-99% -$890K
DOMO icon
1530
Domo
DOMO
$184M
$6K ﹤0.01%
+400
New +$9.66K
EVER icon
1531
EverQuote
EVER
$906M
$6K ﹤0.01%
+300
New +$5.67K
IONS icon
1532
Ionis Pharmaceuticals
IONS
$9.4B
$6K ﹤0.01%
+108
New +$7.04K
IQ icon
1533
CALL
iQIYI
IQ
$1.28B
$6K ﹤0.01%
+400
New +$7.35K
LOVE
1534
LoveSac
LOVE
$261M
$6K ﹤0.01%
300
-10,353
-97% -$217K
MBUU icon
1535
Malibu Boats
MBUU
$567M
$6K ﹤0.01%
+200
New +$6.17K
MRUS
1536
DELISTED
Merus
MRUS
$6K ﹤0.01%
324
-39
-11% -$640
SAP icon
1537
SAP
SAP
$238B
$6K ﹤0.01%
+52
New +$6.44K
TQQQ icon
1538
ProShares UltraPro QQQ
TQQQ
$37.9B
$6K ﹤0.01%
+800
New +$6.34K
TXMD icon
1539
TherapeuticsMD
TXMD
$24M
$6K ﹤0.01%
32
TPC
1540
Tutor Perini Cor
TPC
$5.21B
$6K ﹤0.01%
+400
New +$4.88K
NSTG
1541
DELISTED
NanoString Technologies, Inc.
NSTG
$6K ﹤0.01%
281
-19,352
-99% -$514K
AUY
1542
CALL
DELISTED
Yamana Gold, Inc.
AUY
$6K ﹤0.01%
2,000
AVLR
1543
DELISTED
Avalara, Inc.
AVLR
$6K ﹤0.01%
95
-595
-86% -$48.1K
PING
1544
DELISTED
Ping Identity Holding Corp.
PING
$6K ﹤0.01%
+324
New +$5.89K
GBT
1545
DELISTED
Global Blood Therapeutics, Inc.
GBT
$6K ﹤0.01%
123
-18,033
-99% -$940K
GNMK
1546
DELISTED
GenMark Diagnostics, Inc
GNMK
$6K ﹤0.01%
972
-1,654
-63% -$10.3K
AGYS icon
1547
Agilysys
AGYS
$3.06B
$5K ﹤0.01%
+200
New +$5.09K
CRON
1548
CALL
Cronos Group
CRON
$1.14B
$5K ﹤0.01%
600
ECVT icon
1549
Ecovyst
ECVT
$1.14B
$5K ﹤0.01%
+300
New +$4.59K
GNW icon
1550
Genworth Financial
GNW
$3.71B
$5K ﹤0.01%
1,100
-5,000
-82% -$20.9K

Similar funds

Prelude Capital Management's Q3 2019 Portfolio in Review

As of Q3 2019, Prelude Capital Management held 2,313 positions worth $2.22B, up 9.1% from $2.03B the previous quarter. Its ten largest holdings account for 43% of the portfolio.

Prelude Capital Management deployed $231M of net new capital in Q3 2019, opening 704 new positions and adding to 422 existing holdings. Its largest new stake was Callon Petroleum Company: 418,579 shares worth $18.2M.

By sector, the portfolio is most concentrated in Technology at 6.3% of assets, down from 6.6% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was Stewart Information Services, an estimated $7.45M trimmed.

  • Prelude Capital Management's largest Q3 2019 buy was Callon Petroleum Company: 418,579 shares worth $18.2M.
  • Prelude Capital Management added most to Altaba Inc in Q3 2019, an estimated $29.3M increase.
  • Prelude Capital Management's biggest Q3 2019 reduction was Stewart Information Services, cutting an estimated $7.45M.
  • Prelude Capital Management fully exited Anadarko Petroleum in Q3 2019, selling an estimated $41.9M.
  • Prelude Capital Management's ten largest holdings make up 43% of its $2.22B portfolio in Q3 2019.
  • Prelude Capital Management opened 704 new positions and closed 646 in Q3 2019.
  • Prelude Capital Management's portfolio value rose 9.1% quarter-over-quarter to $2.22B.

Based on Prelude Capital Management's 13F filing for Q3 2019, filed 14 Nov 2019.